Cargando…
YAP and endothelin-1 signaling: an emerging alliance in cancer
The rational making the G protein-coupled receptors (GPCR) the centerpiece of targeted therapies is fueled by the awareness that GPCR-initiated signaling acts as pivotal driver of the early stages of progression in a broad landscape of human malignancies. The endothelin-1 (ET-1) receptors (ET-1R), k...
Autores principales: | Tocci, Piera, Blandino, Giovanni, Bagnato, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797087/ https://www.ncbi.nlm.nih.gov/pubmed/33422090 http://dx.doi.org/10.1186/s13046-021-01827-8 |
Ejemplares similares
-
Functional interaction between endothelin-1 and ZEB1/YAP signaling regulates cellular plasticity and metastasis in high-grade serous ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2022) -
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer
por: Tocci, Piera, et al.
Publicado: (2019) -
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancer
por: Sestito, Rosanna, et al.
Publicado: (2020) -
Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach
por: Tocci, Piera, et al.
Publicado: (2019) -
Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
por: Tocci, Piera, et al.
Publicado: (2023)